open access

Vol 8, No 4 (2004)
Original paper
Published online: 2004-07-22
Get Citation

Influence of L-carnitine supplementation on diurnal blood pressure rhythm in obese type 2 diabetic subjects with autonomic neuropathy

Anna Pikul, Liliana Majkowska, Krzysztof Safranow, Krystyna Pilarska
Nadciśnienie tętnicze 2004;8(4):215-229.

open access

Vol 8, No 4 (2004)
Prace oryginalne
Published online: 2004-07-22

Abstract

Background Diabetic autonomic neuropathy can be associated with abnormalities in diurnal blood pressure rhythm. It has been suggested that carnitine deficiency can be involved in the development of both diabetic neuropathy and insulin resistance. The aim of the study was to assess serum carnitine levels and diurnal blood pressure rhythm in obese type 2 diabetic subjects with subclinical autonomic neuropathy and without neuropathy and to determine influence of L-carnitine supplementation on autonomic neuropathy and blood pressure rhythm.
Material and methods Study was performed in 30 obese type 2 diabetic patients treated with oral antidiabetic agents. Subclinical autonomic neuropathy of cardiovascular system was present in 15 of them - group NA(+) and was not found in 15 others - group NA(-). Control group consisted of 15 obese, nondiabetic subjects. In all subjects body mass index (BMI), waist-hip ratio (WHR), fasting serum free and total carnitine, glucose, insulin, C-peptide, lipids and HbA1c were measured. Assessment of autonomic neuropathy was based on a Ewing’s battery of autonomic function tests. Ambulatory blood pressure monitoring was performed with SpaceLabs 90207. Investigation was performed twice, before and after supplementation of 1000 mg L-carnitine per day, given orally for 3 month.
Results No differences in age, sex, BMI and WHR was found in all investigated groups. Diurnal blood pressure rhythm and number of subjects with normal night blood pressure fall was similar in NA(-) and NA(+) patients. Similar levels of free and total carnitine, glucose, insulin, C-peptide, HbA1c, total cholesterol, LDL, HDL cholesterol and triglicerides were found in NA(+) and NA(-) groups. After supplementation of L-carnitine in diabetic patients, serum carnitine levels increased but there was no change in BMI, autonomic nervous system function and blood pressure rhythm.
Conclusions Subclinical autonomic neuropathy in obese type 2 diabetic subjects is not associated with serum carnitine concentration and abnormalities in blood pressure rhythm. Supplementation of L-carnitine does not influence the autonomic neuropathy and diurnal blood pressure rhythm.

Abstract

Background Diabetic autonomic neuropathy can be associated with abnormalities in diurnal blood pressure rhythm. It has been suggested that carnitine deficiency can be involved in the development of both diabetic neuropathy and insulin resistance. The aim of the study was to assess serum carnitine levels and diurnal blood pressure rhythm in obese type 2 diabetic subjects with subclinical autonomic neuropathy and without neuropathy and to determine influence of L-carnitine supplementation on autonomic neuropathy and blood pressure rhythm.
Material and methods Study was performed in 30 obese type 2 diabetic patients treated with oral antidiabetic agents. Subclinical autonomic neuropathy of cardiovascular system was present in 15 of them - group NA(+) and was not found in 15 others - group NA(-). Control group consisted of 15 obese, nondiabetic subjects. In all subjects body mass index (BMI), waist-hip ratio (WHR), fasting serum free and total carnitine, glucose, insulin, C-peptide, lipids and HbA1c were measured. Assessment of autonomic neuropathy was based on a Ewing’s battery of autonomic function tests. Ambulatory blood pressure monitoring was performed with SpaceLabs 90207. Investigation was performed twice, before and after supplementation of 1000 mg L-carnitine per day, given orally for 3 month.
Results No differences in age, sex, BMI and WHR was found in all investigated groups. Diurnal blood pressure rhythm and number of subjects with normal night blood pressure fall was similar in NA(-) and NA(+) patients. Similar levels of free and total carnitine, glucose, insulin, C-peptide, HbA1c, total cholesterol, LDL, HDL cholesterol and triglicerides were found in NA(+) and NA(-) groups. After supplementation of L-carnitine in diabetic patients, serum carnitine levels increased but there was no change in BMI, autonomic nervous system function and blood pressure rhythm.
Conclusions Subclinical autonomic neuropathy in obese type 2 diabetic subjects is not associated with serum carnitine concentration and abnormalities in blood pressure rhythm. Supplementation of L-carnitine does not influence the autonomic neuropathy and diurnal blood pressure rhythm.
Get Citation

Keywords

diabetes mellitus type 2; obesity; autonomic neuropathy; diurnal blood pressure rhythm; carnitine; L-carnitine

About this article
Title

Influence of L-carnitine supplementation on diurnal blood pressure rhythm in obese type 2 diabetic subjects with autonomic neuropathy

Journal

Arterial Hypertension

Issue

Vol 8, No 4 (2004)

Article type

Original paper

Pages

215-229

Published online

2004-07-22

Page views

2342

Article views/downloads

1458

Bibliographic record

Nadciśnienie tętnicze 2004;8(4):215-229.

Keywords

diabetes mellitus type 2
obesity
autonomic neuropathy
diurnal blood pressure rhythm
carnitine
L-carnitine

Authors

Anna Pikul
Liliana Majkowska
Krzysztof Safranow
Krystyna Pilarska

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl